Medical cannabis production

Health Canada is currently developing a guidance document to address the misuse of the Access to Cannabis for Medical Purposes Program, while also maintaining access for eligible individuals. Interested stakeholders, including local governments, are invited to provide feedback regarding a recently released draft guidance document by May 7, 2021.

A key focus of the guidance document is to formalize a list of reasons why an individual’s medical cannabis production registration may be refused. In addressing this issue, Health Canada is seeking to understand whether the proposed list of factors (as outlined in the draft document) is clear and/or whether there are additional factors that should be considered.

Health Canada intends to follow this consultation process with a ‘What We Heard’ report prior to releasing a final version of the guidance document. 

Meta Navigation